Going Solo Suits Vifor And Its Hopes For Two Blockbusters

Enjoying its independence from Galenica, Switzerland’s third-largest pharmaceutical company believes that Ferinject and Veltassa will help it achieve sales of over CHF2bn by 2020.

Flying
Vifor off to a flying start as an independent company • Source: Shutterstock

More from Earnings

More from Business